Rosemont to expand with buy of Sabal Therapeutics and its affiliates

UK-based liquid medicines maker Rosemont Pharmaceuticals says it has acquired Sabal Therapeutics along with its affiliates.

These comprise Metacel Pharmaceuticals, Palmetto Pharmaceuticals, Athena Bioscience and Sarras Health, a group of privately owned specialty pharmaceutical companies and distributors of prescription, liquid medicines, based in Watkinsville, Georgia, USA.

This acquisition further enhances Rosemont’s ability to serve patients with swallowing difficulties across the USA. Previously, Rosemont has developed, registered and supplied medicines to the US market via distribution partners. This acquisition now provides the company with the ability to supply branded and generic medicines directly into the US market. In addition to the existing portfolio included in this transaction, Rosemont has an extensive pipeline of novel, liquid medicines designed for the US market and patients.